- 2024,11,05
Kang Le, academicians of the CAS Member, and Yang Huanming came to our district and made a special trip to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. for research.
It is reported that Academician Kangle is a famous ecologist and entomologist in China. He is currently the director of the Institute of Zoology, Chinese Academy of Sciences, and the president of the Academy of Life Sciences, University of Chinese Academy of Sciences. Academician Yang Huanming is from Yueqing, Wenzhou, a famous Chinese genetic engineer. He is currently an academician of the Chinese Academy of Sciences, chairman of BGI, and president of BGI College.
At the symposium, Kangle, Yang Huanming and others had a detailed understanding of the difficulties and problems encountered in the production and operation of the enterprise from the person in charge of the company, and had in-depth exchanges with the person in charge of the enterprise on production scale, product types, market share, technological innovation, new product research and development, etc. At the same time, the 13th Five Year Plan of Cheng Yi Pharmaceutical is focused on planning, pointing out the development prospects of marine medicine, biopharmaceuticals, and other fields, providing new ideas for pharmaceutical enterprises in Dongtou that rely on the sea and eat the sea.
They stated that Cheng Yi Pharmaceutical's unique resources provide favorable conditions for pharmaceutical production, and they hope that pharmaceutical companies can utilize this advantage to establish a good brand. We are willing to promote more education and R&D resources to Dongtou based on the successful settlement of Renji College of Wenzhou Medical University in Dongtou, so as to form a local economy with characteristics combining industry, education and research. At the same time, we hope that enterprises can promote relevant pharmaceutical research and development resources to pharmaceutical enterprises in southern Zhejiang, bringing new prospects to them.
It is understood that Academician Yang Huanming has preliminarily decided to accept the invitation for the 50th anniversary celebration of Cheng Yi Pharmaceutical to be held on October 19. At that time, Academician Yang will rely on BGI's world leading technology platforms such as large-scale sequencing and bioinformatics analysis to deeply explain how to extend the traditional Pharmaceutical industry by using the latest biotechnology transformation such as recombinant drugs, biological vaccines and biological diagnostics triggered by genetic technology.